{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:04:28Z","timestamp":1772114668250,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NF20OC0064537"],"award-info":[{"award-number":["NF20OC0064537"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NF20OC0064537"],"award-info":[{"award-number":["NF20OC0064537"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,2,20]]},"DOI":"10.1038\/s41416-025-03316-7","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T17:48:19Z","timestamp":1766166499000},"page":"618-626","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neoplasm risk in individuals with neurofibromatosis 1 \u2013 a Danish nationwide cohort study with long-term follow-up"],"prefix":"10.1038","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1840-7768","authenticated-orcid":false,"given":"Mia Aagaard","family":"Doherty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrine","family":"Grell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Hove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette M.","family":"Handrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Kr\u00f8yer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas T.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4436-6798","authenticated-orcid":false,"given":"Henrik","family":"Hjalgrim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Mulvihill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Wohlfahrt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3976-9231","authenticated-orcid":false,"given":"Henrik","family":"Hasle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilie","family":"Ejerskov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3584-6570","authenticated-orcid":false,"given":"Line","family":"Kenborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"3316_CR1","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/jid.2014.465","volume":"135","author":"E Uusitalo","year":"2015","unstructured":"Uusitalo E, Leppavirta J, Koffert A, Suominen S, Vahtera J, Vahlberg T, et al. Incidence and mortality of neurofibromatosis: a total population study in Finland. J Invest Dermatol. 2015;135:904\u20136.","journal-title":"J Invest Dermatol"},{"key":"3316_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152A","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010;152A:327\u201332.","journal-title":"Am J Med Genet A"},{"key":"3316_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.4","volume":"3","author":"DH Gutmann","year":"2017","unstructured":"Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Rev Dis Primers. 2017;3:17004.","journal-title":"Nat Rev Dis Primers"},{"key":"3316_CR4","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","volume":"23","author":"E Legius","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. 2021;23:1506\u201313.","journal-title":"Genet Med"},{"key":"3316_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1046\/j.1525-1470.2001.01976.x","volume":"18","author":"L Dupuis","year":"2001","unstructured":"Dupuis L, Nezarati MM. Neurofibromatosis type I as a model of autosomal dominant inheritance. Pediatr Dermatol. 2001;18:445\u20137.","journal-title":"Pediatr Dermatol"},{"key":"3316_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","volume":"62","author":"GF Xu","year":"1990","unstructured":"Xu GF, O\u2019Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell. 1990;62:599\u2013608.","journal-title":"Cell"},{"key":"3316_CR7","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","volume":"34","author":"E Uusitalo","year":"2016","unstructured":"Uusitalo E, Rantanen M, Kallionpaa RA, Poyhonen M, Leppavirta J, Yla-Outinen H, et al. Distinctive cancer associations in patients with neurofibromatosis type 1. J Clin Oncol. 2016;34:1978\u201386.","journal-title":"J Clin Oncol"},{"key":"3316_CR8","doi-asserted-by":"publisher","first-page":"e210945","DOI":"10.1001\/jamanetworkopen.2021.0945","volume":"4","author":"JP Landry","year":"2021","unstructured":"Landry JP, Schertz KL, Chiang YJ, Bhalla AD, Yi M, Keung EZ, et al. Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020. JAMA Netw Open. 2021;4:e210945.","journal-title":"JAMA Netw Open"},{"key":"3316_CR9","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1016\/j.jid.2023.04.034","volume":"143","author":"E Diaz","year":"2023","unstructured":"Diaz E, Bergqvist C, Peiffer B, Fertitta L, Jannic A, Ferkal S, et al. In-hospital clinical features, morbidity, and mortality of patients with neurofibromatosis 1 in France: a nationwide, population-based retrospective cohort study. J Invest Dermatol. 2023;143:2408\u201315.e7.","journal-title":"J Invest Dermatol"},{"key":"3316_CR10","doi-asserted-by":"publisher","first-page":"e065340","DOI":"10.1136\/bmjopen-2022-065340","volume":"12","author":"K Doser","year":"2022","unstructured":"Doser K, Hove H, Ostergaard JR, Bidstrup PE, Dalton SO, Handrup MM, et al. Cohort profile: life with neurofibromatosis 1 - the Danish NF1 cohort. BMJ Open. 2022;12:e065340.","journal-title":"BMJ Open"},{"key":"3316_CR11","unstructured":"RAREDIS. Database for rare genetic diseases in Denmark. 2025. Available from: www.raredis.eu. Accessed Nov 2024."},{"key":"3316_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449\u201390.","journal-title":"Clin Epidemiol"},{"key":"3316_CR13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/s41436-020-0769-6","volume":"22","author":"L Kenborg","year":"2020","unstructured":"Kenborg L, Duun-Henriksen AK, Dalton SO, Bidstrup PE, Doser K, Rugbjerg K, et al. Multisystem burden of neurofibromatosis 1 in Denmark: registry- and population-based rates of hospitalizations over the life span. Genet Med. 2020;22:1069\u201378.","journal-title":"Genet Med"},{"key":"3316_CR14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","volume":"45","author":"Neurofibromatosis","year":"1988","unstructured":"Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988;45:575\u20138.","journal-title":"Arch Neurol"},{"key":"3316_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541\u20139.","journal-title":"Eur J Epidemiol"},{"key":"3316_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1403494811399958","volume":"39","author":"K Helweg-Larsen","year":"2011","unstructured":"Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health. 2011;39:26\u20139.","journal-title":"Scand J Public Health"},{"key":"3316_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1403494810393562","volume":"39","author":"ML Gjerstorff","year":"2011","unstructured":"Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39:42\u20135.","journal-title":"Scand J Public Health"},{"key":"3316_CR18","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/ijc.32187","volume":"145","author":"S Peltonen","year":"2019","unstructured":"Peltonen S, Kallionpaa RA, Rantanen M, Uusitalo E, Lahteenmaki PM, Poyhonen M, et al. Pediatric malignancies in neurofibromatosis type 1: a population-based cohort study. Int J Cancer. 2019;145:2926\u201332.","journal-title":"Int J Cancer"},{"key":"3316_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.bjc.6603227","volume":"95","author":"L Walker","year":"2006","unstructured":"Walker L, Thompson D, Easton D, Ponder B, Ponder M, Frayling I, et al. A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer. 2006;95:233\u20138.","journal-title":"Br J Cancer"},{"key":"3316_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3929-6","volume":"17","author":"E Lynge","year":"2017","unstructured":"Lynge E, Bak M, von Euler-Chelpin M, Kroman N, Lernevall A, Mogensen NB, et al. Outcome of breast cancer screening in Denmark. BMC Cancer. 2017;17:897.","journal-title":"BMC Cancer"},{"key":"3316_CR21","unstructured":"Danish Society of Medical Genetics. 2025. Available from: www.dmcg.dk."},{"key":"3316_CR22","unstructured":"Breast cancer screening recommendation for women with NF1 in Denmark from the Danish Breast Cancer Group (DBCG - Dansk Brystcancer Gruppe). 2025. Available from: https:\/\/www.dmcg.dk\/globalassets\/generel-overflytning\/dmcg\/kliniske-retningslinjer---skabeloner-og-vejledninger\/kliniske-retningslinjer-opdelt-pa-dmcg\/dbcg\/dbcg_arvelig-cancer-mamma_v.2.0_admgodk_02012023.pdf."},{"key":"3316_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/bjc.2016.403","volume":"116","author":"E Uusitalo","year":"2017","unstructured":"Uusitalo E, Kallionpaa RA, Kurki S, Rantanen M, Pitkaniemi J, Kronqvist P, et al. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors. Br J Cancer. 2017;116:211\u20137.","journal-title":"Br J Cancer"},{"key":"3316_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2018.03.062","volume":"155","author":"MB Larsen","year":"2018","unstructured":"Larsen MB, Njor S, Ingeholm P, Andersen B. Effectiveness of colorectal cancer screening in detecting earlier-stage disease-a nationwide cohort study in Denmark. Gastroenterology. 2018;155:99\u2013106.","journal-title":"Gastroenterology"},{"key":"3316_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.927","volume":"7","author":"H Yla-Outinen","year":"2019","unstructured":"Yla-Outinen H, Loponen N, Kallionpaa RA, Peltonen S, Peltonen J. Intestinal tumors in neurofibromatosis 1 with special reference to fatal gastrointestinal stromal tumors (GIST). Mol Genet Genomic Med. 2019;7:e927.","journal-title":"Mol Genet Genomic Med"},{"key":"3316_CR26","doi-asserted-by":"publisher","first-page":"e2325482","DOI":"10.1001\/jamanetworkopen.2023.25482","volume":"6","author":"CE Kampitsi","year":"2023","unstructured":"Kampitsi CE, Nordgren A, Mogensen H, Ponten E, Feychting M, Tettamanti G. Neurocutaneous syndromes, perinatal factors, and the risk of childhood cancer in Sweden. JAMA Netw Open. 2023;6:e2325482.","journal-title":"JAMA Netw Open"},{"key":"3316_CR27","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2147\/CMAR.S362678","volume":"15","author":"Y Tang","year":"2023","unstructured":"Tang Y, Gutmann DH. Neurofibromatosis type 1-associated optic pathway gliomas: current challenges and future prospects. Cancer Manag Res. 2023;15:667\u201381.","journal-title":"Cancer Manag Res"},{"key":"3316_CR28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.ncl.2007.07.008","volume":"25","author":"CJ Farrell","year":"2007","unstructured":"Farrell CJ, Plotkin SR. Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes. Neurol Clin. 2007;25:925\u201346, viii.","journal-title":"Neurol Clin"},{"key":"3316_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01856-8","volume":"16","author":"C Bergqvist","year":"2021","unstructured":"Bergqvist C, Hemery F, Jannic A, Ferkal S, Wolkenstein P. Lymphoproliferative malignancies in patients with neurofibromatosis 1. Orphanet J Rare Dis. 2021;16:230.","journal-title":"Orphanet J Rare Dis"},{"key":"3316_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/bjc.2012.535","volume":"108","author":"OO Seminog","year":"2013","unstructured":"Seminog OO, Goldacre MJ. Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study. Br J Cancer. 2013;108:193\u20138.","journal-title":"Br J Cancer"},{"key":"3316_CR31","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1200\/JCO.19.00114","volume":"37","author":"S Bhatia","year":"2019","unstructured":"Bhatia S, Chen Y, Wong FL, Hageman L, Smith K, Korf B, et al. Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1. J Clin Oncol. 2019;37:3050\u20138.","journal-title":"J Clin Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03316-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03316-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03316-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:55:08Z","timestamp":1769770508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03316-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2,20]]}},"alternative-id":["3316"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03316-7","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Following the General Data Protection Regulation, the study is registered in the Danish Cancer Institute\u2019s local archive (record number 2019-DCRC-0063). According to Danish regulations, ethics approval and informed consent are not required for studies using only register data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}